Open, single centre, pilot study to investigate a steroid free immunosuppressive regimen for de novo renal transplant recipients followed by randomisation to calcineurin inhibitor containing or calcineurin inhibitor free immunosuppression
Phase of Trial: Phase IV
Latest Information Update: 01 Dec 2012
At a glance
- Drugs Mycophenolate sodium (Primary) ; Sirolimus (Primary) ; Tacrolimus (Primary) ; Basiliximab; Methylprednisolone
- Indications Renal transplant rejection
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 29 Jun 2010 Actual patient number (100) added as reported by ClinicalTrials.gov.
- 29 Jun 2010 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.